As of 2025-10-27, the Relative Valuation of BioXcel Therapeutics Inc (BTAI) is (37.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.33 USD, the upside of BioXcel Therapeutics Inc based on Relative Valuation is -1721.9%.
The range of the Relative Valuation is (36.46) - (39.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 15.1x | 14.6x |
| Forward P/E multiples | 14.0x - 15.1x | 14.6x |
| Fair Price | (36.46) - (39.20) | (37.79) |
| Upside | -1664.6% - -1782.6% | -1721.9% |
| Date | P/E |
| 2025-10-17 | -0.89 |
| 2025-10-16 | -0.95 |
| 2025-10-15 | -1.03 |
| 2025-10-14 | -1.01 |
| 2025-10-13 | -1.01 |
| 2025-10-10 | -0.98 |
| 2025-10-09 | -1.07 |
| 2025-10-08 | -1.03 |
| 2025-10-07 | -0.96 |
| 2025-10-06 | -0.98 |
| 2025-10-03 | -0.98 |
| 2025-10-02 | -1.02 |
| 2025-10-01 | -0.99 |
| 2025-09-30 | -0.99 |
| 2025-09-29 | -1.01 |
| 2025-09-26 | -1.04 |
| 2025-09-25 | -1.09 |
| 2025-09-24 | -1.00 |
| 2025-09-23 | -0.95 |
| 2025-09-22 | -1.07 |
| 2025-09-19 | -1.15 |
| 2025-09-18 | -1.16 |
| 2025-09-17 | -1.12 |
| 2025-09-16 | -1.15 |
| 2025-09-15 | -1.22 |
| 2025-09-12 | -1.20 |
| 2025-09-11 | -1.31 |
| 2025-09-10 | -1.36 |
| 2025-09-09 | -1.38 |
| 2025-09-08 | -1.63 |
| 2025-09-05 | -1.46 |
| 2025-09-04 | -1.38 |
| 2025-09-03 | -1.40 |
| 2025-09-02 | -1.47 |
| 2025-08-29 | -1.56 |
| 2025-08-28 | -1.58 |
| 2025-08-27 | -1.53 |
| 2025-08-26 | -2.02 |
| 2025-08-25 | -1.99 |
| 2025-08-22 | -1.92 |
| 2025-08-21 | -2.02 |
| 2025-08-20 | -1.94 |
| 2025-08-19 | -1.90 |
| 2025-08-18 | -2.19 |
| 2025-08-15 | -2.11 |
| 2025-08-14 | -1.83 |
| 2025-08-13 | -2.16 |
| 2025-08-12 | -2.62 |
| 2025-08-11 | -2.47 |
| 2025-08-08 | -1.56 |